The dysregulation of lncRNAs by epigenetic factors in human pathologies

Yanli Zhang1, Xiaocong Wang2, Chen Zhang3

  • 1Central Laboratory, The First Hospital of Jilin University, Changchun, Jilin, China; Key Laboratory of Organ Regeneration and Transplantation, Ministry of Education, Changchun, Jilin 130021, China; Department of Echocardiography, The First Hospital of Jilin University, Changchun, Jilin, China.

Drug Discovery Today
|June 22, 2023
PubMed

Insights

Long noncoding RNAs (lncRNAs) are crucial in diseases like cancer and autoimmune diseases (ADs). This review explores how epigenetic factors dysregulate lncRNAs, offering insights for new AD therapies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Immunology

Background:

  • Long noncoding RNAs (lncRNAs) play significant roles in the initiation and progression of various human diseases.
  • Dysregulation of lncRNAs is implicated in pathologies such as cancers and autoimmune diseases (ADs).
  • Understanding the complex regulatory networks of lncRNAs is essential for developing novel therapeutic strategies for ADs.

Purpose of the Study:

  • To review the mechanisms by which epigenetic factors dysregulate lncRNAs in pathological conditions.
  • To discuss the involvement of lncRNA epigenetic regulators in immune responses and autoimmune diseases.
  • To provide a theoretical foundation for the clinical application of lncRNAs in ADs.

Main Methods:

  • Literature review summarizing epigenetic regulation of lncRNAs.
  • Analysis of lncRNA dysregulation by epigenetic factors including RNA-binding proteins and chemical modifications.
  • Discussion of the roles of lncRNA epigenetic regulators in immune response and ADs.

Main Results:

  • Epigenetic factors such as RNA-binding proteins, chemical modifications (e.g., N6-methyladenosine, DNA methylation, histone modification), microRNA, and alternative splicing contribute to lncRNA dysregulation.
  • lncRNA epigenetic regulators are involved in immune responses and the pathogenesis of autoimmune diseases.
  • A complex interplay exists between epigenetic factors and lncRNAs in disease development.

Conclusions:

  • Epigenetic dysregulation of lncRNAs is a key factor in the pathogenesis of autoimmune diseases.
  • Targeting the epigenetic regulation of lncRNAs presents a promising avenue for developing new therapies for ADs.
  • Further research into the epigenetic factor-lncRNA network will advance the clinical application of lncRNAs for treating ADs.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.1K
Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
9.2K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
8.3K